The demonstration of value and optimal access is the most fundamental challenge and opportunity for any brand irrespective of where it is in its lifecycle. We support biopharmaceutical companies to optimize pricing and access for therapeutics by dovetailing these with overall commercialisation objectives, contextualised within market specific evidence requirement, and alignment with payer goals.
Our expertise in pricing and access paired with a strategy consultant approach, allow us to help our clients navigate complex pricing and market access environments. Our deep market specific insights help shape and refine pricing and access strategies and support their implementation in health technology evaluations. The mix of pricing and market access, and broader commercial expertise allows us to serve our clients market access, clinical and commercial teams.
Market Access Strategy Development
Ensuring products can achieve their full potential and deliver the most benefits to patients across markets
- Market Access Opportunity Assessment
- Primary Market Research (Payer & KOL)
- Pricing assessments (analogue & qual. PMR)
- Indication prioritization & sequencing
Development of Core Deliverables & Launch Readiness
Turning complex and heterogeneous challenges into simple and digestible deliverables for teams to leverage
- Payer Value Story & Objection handler
- Negotiation strategy guide playbooks
- Managed Entry Agreement (MEA) frameworks
- Contracting & Tendering playbooks
Localization of Access Strategies & Execution Support
Supporting and empowering local tam to optimally execute ambitious access goals
- Training & immersion into Global strategic deliverables
- Localization of access strategies
- Mock payer negotiations
